| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |